Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
Etienne Léveillé, Nathalie A. Johnson
Cancers (2021) Vol. 13, Iss. 9, pp. 2167-2167
Open Access | Times Cited: 17

Showing 17 citing articles:

Ferroptosis: A New Regulatory Mechanism in Osteoporosis
Pan Liu, Wenzhao Wang, Zheng Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 99
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis
Anja Schmitt, Melanie Grimm, Nina Kreienkamp, et al.
Blood (2023) Vol. 142, Iss. 13, pp. 1143-1155
Closed Access | Times Cited: 27
SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
Zi‐Wen Duan, Wei‐Ting Wang, Yan Wang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans
Quentin Riller, Boris Sorin, Charline Courteille, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 2
Closed Access
Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma
ChaoFeng Zhang, Qi Lin, Chuntuan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
Mei‐wei Li, Fengxiang Huang, Zucheng Xie, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3812-3829
Open Access | Times Cited: 9
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach
Fleur A. de Groot, Ruben A. L. de Groen, Anke van den Berg, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1857-1857
Open Access | Times Cited: 8
Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets
Wen Wen, Wenlu Zhang, Ran Tan, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 7, pp. 3280-3293
Open Access | Times Cited: 1
The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes
Amr Awaad, Zakia A. Olama, Gehan M. El‐Subruiti, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Samuel E.J. Preston, Audrey Émond, Filippa Pettersson, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 4, pp. 511-521
Open Access | Times Cited: 3
Effect of P53 expression on double-expressor lymphoma and characteristics of DLBCL co-expressing P53 and MYC: Clinical, pathological, and biological insights
Yi-Zhuo Chen, Jin-Ling Bo, Shuling Hou
Asian Journal of Surgery (2024) Vol. 47, Iss. 6, pp. 2852-2855
Open Access
Compound heterozygous mutations in the kinase domain of IKKα lead to immunodeficiency and immune dysregulation
Quentin Riller, Boris Sorin, Charline Courteille, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma
Osama M. Al‐Amer, Rashid Mir, Abdullah Hamadi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 1
Association of p53 protein expression with the presence of a 17p13 locus deletion of the TP53 gene and with the survival of patients with diffuse large B-cell lymphoma
Mariia V. Sarpova, Elena Vaneeva, Д. А. Дьяконов, et al.
Kazan medical journal (2023) Vol. 104, Iss. 1, pp. 38-46
Open Access
Data from Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Samuel E.J. Preston, Audrey Émond, Filippa Pettersson, et al.
(2023)
Open Access
Supplementary Data from Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Samuel E.J. Preston, Audrey Émond, Filippa Pettersson, et al.
(2023)
Open Access
Data from Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Samuel E.J. Preston, Audrey Émond, Filippa Pettersson, et al.
(2023)
Open Access
Page 1

Scroll to top